Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico

Anxiety-related disorders are one of the most common mental health issues worldwide. Mexico has reported an increase in the prevalence of these ailments secondary to the confinement derived from the COVID-19 pandemic. Given the limitations of commonly used treatments for these disorders, a need aris...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz Rios, Flor Cristina, Dávila Ruiz, Itzel Guadalupe, Sacal Dumani, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491383/
https://www.ncbi.nlm.nih.gov/pubmed/36188636
http://dx.doi.org/10.7573/dic.2022-3-2
Descripción
Sumario:Anxiety-related disorders are one of the most common mental health issues worldwide. Mexico has reported an increase in the prevalence of these ailments secondary to the confinement derived from the COVID-19 pandemic. Given the limitations of commonly used treatments for these disorders, a need arises to develop new pharmacological treatments for these patients. This paper has the primary objective of evaluating the efficacy and safety of cannabidiol isolate in drug compounding used as a personalized treatment in patients with anxiety disorders through the presentation of four clinical cases.

Ejemplares similares